4-Phenylbutyric Acid
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Prednisone.
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Prednisone.
Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Prednisone.
Advertisement
Acemetacin
The risk or severity of adverse effects can be increased when Acemetacin is combined with Prednisone.
Acetohexamide
The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Prednisone.
Acetyl salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.
Advertisement
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Prednisone.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Prednisone.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Prednisone.
Advertisement
Aldesleukin
Prednisone may decrease the antineoplastic activities of Aldesleukin.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Prednisone.
Alogliptin
The therapeutic efficacy of Alogliptin can be decreased when used in combination with Prednisone.
Aloxiprin
The risk or severity of adverse effects can be increased when Aloxiprin is combined with Prednisone.
Aluminum
The bioavailability of Prednisone can be decreased when combined with Aluminium.
Aluminum Hydroxide
The bioavailability of Prednisone can be decreased when combined with Aluminum hydroxide.
aluminum hydroxide, dried (USP)
The bioavailability of Prednisone can be decreased when combined with Aluminum hydroxide.
Aluminum Magnesium Silicate
The bioavailability of Prednisone can be decreased when combined with Almasilate.
Ambenonium
The risk or severity of adverse effects can be increased when Prednisone is combined with Ambenonium.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Aminosalicylic Acid is combined with Prednisone.
Amiodarone
The serum concentration of Prednisone can be increased when it is combined with Amiodarone.
Amphotericin B
Prednisone may increase the hypokalemic activities of Amphotericin B.
amphotericin B liposomal
Prednisone may increase the hypokalemic activities of Amphotericin B.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Prednisone.
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Prednisone.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Prednisone is combined with Anthrax immune globulin human.
Antipyrine
The risk or severity of adverse effects can be increased when Antipyrine is combined with Prednisone.
Apalutamide
The serum concentration of Prednisone can be decreased when it is combined with Apalutamide.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Prednisone.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Prednisone.
Aprepitant
The serum concentration of Prednisone can be increased when it is combined with Aprepitant.
Aripiprazole
The serum concentration of Aripiprazole can be decreased when it is combined with Prednisone.
Aspirin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.
Atazanavir
The serum concentration of Prednisone can be increased when it is combined with Atazanavir.
Atomoxetine
The metabolism of Prednisone can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Prednisone is combined with Atorvastatin.
Atracurium Besylate
Atracurium besylate may increase the adverse neuromuscular activities of Prednisone.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Prednisone.
Azosemide
Prednisone may increase the hypokalemic activities of Azosemide.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Prednisone.
BCG Vaccine
The risk or severity of adverse effects can be increased when Prednisone is combined with BCG vaccine.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Prednisone is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Prednisone is combined with Bacillus calmette-guerin substrain tice live antigen.
Bendroflumethiazide
Prednisone may increase the hypokalemic activities of Bendroflumethiazide.
Benzoic Acid
The therapeutic efficacy of Benzoic Acid can be decreased when used in combination with Prednisone.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Prednisone.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Prednisone.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Prednisone.
Bismuth Subcitrate
The bioavailability of Prednisone can be decreased when combined with Bismuth Subcitrate.
Boceprevir
The serum concentration of Prednisone can be increased when it is combined with Boceprevir.
Bortezomib
The metabolism of Prednisone can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Prednisone can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Prednisone.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Prednisone.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Prednisone.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Prednisone.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Prednisone.
Bufexamac
The risk or severity of adverse effects can be increased when Bufexamac is combined with Prednisone.
Bumetanide
Prednisone may increase the hypokalemic activities of Bumetanide.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Prednisone.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Prednisone.
Calcitriol
The therapeutic efficacy of Calcitriol can be decreased when used in combination with Prednisone.
Calcium Carbonate
The bioavailability of Prednisone can be decreased when combined with Calcium Carbonate.
CALCIUM CARBONATE, PRECIPITATED
The bioavailability of Prednisone can be decreased when combined with Calcium Carbonate.
Canagliflozin
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Prednisone.
Canagliflozin Anhydrous
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Prednisone.
Capromab Pendetide
Prednisone may decrease effectiveness of Capromab pendetide as a diagnostic agent.
Carbamazepine
The serum concentration of Prednisone can be decreased when it is combined with Carbamazepine.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Prednisone.
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Prednisone.
Ceritinib
The serum concentration of Prednisone can be increased when it is combined with Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Prednisone.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Prednisone.
Chlorothiazide
Prednisone may increase the hypokalemic activities of Chlorothiazide.
Chlorotrianisene
The serum concentration of Prednisone can be increased when it is combined with Chlorotrianisene.
Chlorpropamide
The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Prednisone.
Chlorthalidone
Prednisone may increase the hypokalemic activities of Chlorthalidone.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Prednisone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Prednisone.
Cinoxacin
The risk or severity of adverse effects can be increased when Prednisone is combined with Cinoxacin.
Clarithromycin
The serum concentration of Prednisone can be increased when it is combined with Clarithromycin.
Clemastine
The metabolism of Prednisone can be decreased when combined with Clemastine.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Prednisone.
Clotrimazole
The metabolism of Prednisone can be decreased when combined with Clotrimazole.
Cobicistat
The serum concentration of Prednisone can be increased when it is combined with Cobicistat.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Prednisone.
Colesevelam
Colesevelam can cause a decrease in the absorption of Prednisone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Prednisone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Prednisone.
Corticorelin Ovine
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Prednisone.
Corticorelin Ovine Triflutate
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Prednisone.
Crizotinib
The metabolism of Prednisone can be decreased when combined with Crizotinib.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Prednisone.
Cyclopenthiazide
Prednisone may increase the hypokalemic activities of Cyclopenthiazide.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Prednisone.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Prednisone.
Cyclosporine
The serum concentration of the active metabolites of Prednisone can be increased when Prednisone is used in combination with Cyclosporine.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Prednisone.
Dabrafenib
The serum concentration of Prednisone can be decreased when it is combined with Dabrafenib.
Danazol
Prednisone may increase the fluid retaining activities of Danazol.
Darunavir
The serum concentration of Prednisone can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Prednisone can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Prednisone can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Prednisone can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Prednisone can be decreased when combined with Delavirdine.
Demecarium
The risk or severity of adverse effects can be increased when Prednisone is combined with Demecarium.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Prednisone.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Prednisone.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Prednisone.
Dienestrol
The serum concentration of Prednisone can be increased when it is combined with Dienestrol.
Diethylstilbestrol
The serum concentration of Prednisone can be increased when it is combined with Diethylstilbestrol.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Prednisone.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Prednisone.
Digoxin
Digoxin may decrease the cardiotoxic activities of Prednisone.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Prednisone.
Diltiazem
The metabolism of Prednisone can be decreased when combined with Diltiazem.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Prednisone.
Distigmine
The risk or severity of adverse effects can be increased when Prednisone is combined with Distigmine.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Prednisone.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Prednisone.
Donepezil
The risk or severity of adverse effects can be increased when Prednisone is combined with Donepezil.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Prednisone.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Prednisone.
Doxycycline
The metabolism of Prednisone can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Prednisone can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Prednisone can be decreased when combined with Dronedarone.
Droxicam
The risk or severity of adverse effects can be increased when Droxicam is combined with Prednisone.
Dulaglutide
The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Prednisone.
Echothiophate
The risk or severity of adverse effects can be increased when Prednisone is combined with Echothiophate.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Prednisone.
Edrophonium
The risk or severity of adverse effects can be increased when Prednisone is combined with Edrophonium.
Empagliflozin
The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Prednisone.
Enoxacin
The risk or severity of adverse effects can be increased when Prednisone is combined with Enoxacin.
Enzalutamide
The serum concentration of Prednisone can be decreased when it is combined with Enzalutamide.
Equol, (-)-
The serum concentration of Prednisone can be increased when it is combined with Equol.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Prednisone.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Prednisone.
Erythromycin
The metabolism of Prednisone can be decreased when combined with Erythromycin.
Estradiol
The serum concentration of Prednisone can be increased when it is combined with Estradiol.
Estradiol acetate
The serum concentration of Prednisone can be increased when it is combined with Estradiol acetate.
Estradiol Cypionate
The serum concentration of Prednisone can be increased when it is combined with Estradiol cypionate.
Estradiol Valerate
The serum concentration of Prednisone can be increased when it is combined with Estradiol valerate.
Estriol
The serum concentration of Prednisone can be increased when it is combined with Estriol.
Estrogens, Conjugated (USP)
The serum concentration of Prednisone can be increased when it is combined with Conjugated estrogens.
Estrogens, Esterified (USP)
The serum concentration of Prednisone can be increased when it is combined with Estrogens, esterified.
Estrone
The serum concentration of Prednisone can be increased when it is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Prednisone.
Ethacrynate
Prednisone may increase the hypokalemic activities of Etacrynic acid.
Ethacrynic Acid
Prednisone may increase the hypokalemic activities of Etacrynic acid.
Ethinyl Estradiol
The serum concentration of Prednisone can be increased when it is combined with Ethinyl Estradiol.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Prednisone.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Prednisone.
Etoricoxib
The risk or severity of adverse effects can be increased when Etoricoxib is combined with Prednisone.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Prednisone.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Prednisone.
Exenatide
The therapeutic efficacy of Exenatide can be decreased when used in combination with Prednisone.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Prednisone.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Prednisone.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Prednisone.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ferulic acid is combined with Prednisone.
Fingolimod
Prednisone may increase the immunosuppressive activities of Fingolimod.
Fleroxacin
The risk or severity of adverse effects can be increased when Prednisone is combined with Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Prednisone.
Fluconazole
The serum concentration of Prednisone can be increased when it is combined with Fluconazole.
Flumequine
The risk or severity of adverse effects can be increased when Prednisone is combined with Flumequine.
Fluoxymesterone
Prednisone may increase the fluid retaining activities of Fluoxymesterone.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Prednisone.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Prednisone.
Fluvoxamine
The metabolism of Prednisone can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Prednisone can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Prednisone can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The serum concentration of Prednisone can be decreased when it is combined with Fosphenytoin.
Furosemide
Prednisone may increase the hypokalemic activities of Furosemide.
Fusidate
The serum concentration of Prednisone can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Prednisone can be increased when it is combined with Fusidic Acid.
Galantamine
The risk or severity of adverse effects can be increased when Prednisone is combined with Galantamine.
Gallamine Triethiodide
The risk or severity of adverse effects can be increased when Prednisone is combined with Gallamine Triethiodide.
Gatifloxacin
The risk or severity of adverse effects can be increased when Prednisone is combined with Gatifloxacin.
Gatifloxacin Anhydrous
The risk or severity of adverse effects can be increased when Prednisone is combined with Gatifloxacin.
Gemifloxacin
The risk or severity of adverse effects can be increased when Prednisone is combined with Gemifloxacin.
Gemifloxacin Mesylate
The risk or severity of adverse effects can be increased when Prednisone is combined with Gemifloxacin.
Genistein
The serum concentration of Prednisone can be increased when it is combined with Genistein.
Ginkgo biloba extract
The risk or severity of adverse effects can be increased when Prednisone is combined with Ginkgo biloba.
Glibornuride
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Prednisone.
Gliclazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Prednisone.
Glimepiride
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Prednisone.
Glipizide
The therapeutic efficacy of Glipizide can be decreased when used in combination with Prednisone.
Gliquidone
The therapeutic efficacy of Gliquidone can be decreased when used in combination with Prednisone.
Glyburide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Prednisone.
Glycerol Phenylbutyrate
The therapeutic efficacy of Glycerol Phenylbutyrate can be decreased when used in combination with Prednisone.
Grepafloxacin
The risk or severity of adverse effects can be increased when Prednisone is combined with Grepafloxacin.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Prednisone is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Prednisone is combined with Hepatitis B Vaccine (Recombinant).
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Prednisone.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Prednisone.
Hydrochlorothiazide
Prednisone may increase the hypokalemic activities of Hydrochlorothiazide.
Hydroflumethiazide
Prednisone may increase the hypokalemic activities of Hydroflumethiazide.
Hydrotalcite
The bioavailability of Prednisone can be decreased when combined with Hydrotalcite.
Hypoxis hemerocallidea root extract
The serum concentration of Prednisone can be decreased when it is combined with St. John's Wort.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Prednisone.
Ibuprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Prednisone.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Prednisone.
Idelalisib
The serum concentration of Prednisone can be increased when it is combined with Idelalisib.
Imatinib
The metabolism of Prednisone can be decreased when combined with Imatinib.
Indacaterol
Indacaterol may increase the hypokalemic activities of Prednisone.
Indapamide
Prednisone may increase the hypokalemic activities of Indapamide.
Indinavir
The serum concentration of Prednisone can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Prednisone can be increased when it is combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Prednisone.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Prednisone.
Insulin Detemir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Prednisone.
Insulin Glargine
The therapeutic efficacy of Insulin Glargine can be decreased when used in combination with Prednisone.
insulin human, rDNA origin
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Prednisone.
Insulin Lispro
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Prednisone.
Insulin, Aspart Protamine, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Prednisone.
Insulin, Aspart, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Prednisone.
Insulin, Glulisine, Human
The therapeutic efficacy of Insulin Glulisine can be decreased when used in combination with Prednisone.
Insulin, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Prednisone.
Insulin, Protamine Lispro, Human
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Prednisone.
Insulin, Regular, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Prednisone.
Isavuconazole
The serum concentration of Prednisone can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Prednisone can be decreased when combined with Isavuconazonium.
Isoflurophate
The risk or severity of adverse effects can be increased when Prednisone is combined with Isoflurophate.
Isoniazid
The serum concentration of Isoniazid can be decreased when it is combined with Prednisone.
Isradipine
The metabolism of Prednisone can be decreased when combined with Isradipine.
Itraconazole
The serum concentration of Prednisone can be increased when it is combined with Itraconazole.
Ivacaftor
The serum concentration of Prednisone can be increased when it is combined with Ivacaftor.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Prednisone.
Ketoconazole
The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Prednisone.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Prednisone.
Lacidipine
The serum concentration of Lacidipine can be decreased when it is combined with Prednisone.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Prednisone.
Leflunomide
The risk or severity of adverse effects can be increased when Prednisone is combined with Leflunomide.
Levofloxacin
The risk or severity of adverse effects can be increased when Prednisone is combined with Levofloxacin.
Levofloxacin Anhydrous
The risk or severity of adverse effects can be increased when Prednisone is combined with Levofloxacin.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Prednisone.
Linagliptin
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Prednisone.
Liraglutide
The therapeutic efficacy of Liraglutide can be decreased when used in combination with Prednisone.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Prednisone.
Lopinavir
The serum concentration of Prednisone can be increased when it is combined with Lopinavir.
Lornoxicam
The risk or severity of adverse effects can be increased when Lornoxicam is combined with Prednisone.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Prednisone.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Prednisone.
Luliconazole
The serum concentration of Prednisone can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Prednisone can be decreased when it is combined with Lumacaftor.
Magaldrate
The bioavailability of Prednisone can be decreased when combined with Magaldrate.
Magnesium Hydroxide
The bioavailability of Prednisone can be decreased when combined with Magnesium hydroxide.
Magnesium Oxide
The bioavailability of Prednisone can be decreased when combined with Magnesium oxide.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Prednisone.
Magnesium Trisilicate
The bioavailability of Prednisone can be decreased when combined with Magnesium Trisilicate.
Malathion
The risk or severity of adverse effects can be increased when Prednisone is combined with Malathion.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Prednisone.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Prednisone.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Prednisone.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Prednisone.
Mefloquine
The risk or severity of adverse effects can be increased when Prednisone is combined with Mefloquine.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Prednisone.
Memantine
The risk or severity of adverse effects can be increased when Prednisone is combined with Memantine.
Mesalamine
The risk or severity of adverse effects can be increased when Mesalazine is combined with Prednisone.
Mesterolone
Prednisone may increase the fluid retaining activities of Mesterolone.
Mestranol
The serum concentration of Prednisone can be increased when it is combined with Mestranol.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Prednisone.
Metformin
The therapeutic efficacy of Metformin can be decreased when used in combination with Prednisone.
Methyclothiazide
Prednisone may increase the hypokalemic activities of Methyclothiazide.
Methyl Salicylate
The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Prednisone.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Prednisone.
Methyltestosterone
Prednisone may increase the fluid retaining activities of Methyltestosterone.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Prednisone.
Metoclopramide
The risk or severity of adverse effects can be increased when Prednisone is combined with Metoclopramide.
Metolazone
Prednisone may increase the hypokalemic activities of Metolazone.
Mifepristone
The therapeutic efficacy of Prednisone can be decreased when used in combination with Mifepristone.
Miglitol
The therapeutic efficacy of Miglitol can be decreased when used in combination with Prednisone.
Miglustat
The therapeutic efficacy of Miglustat can be decreased when used in combination with Prednisone.
Minaprine
The risk or severity of adverse effects can be increased when Prednisone is combined with Minaprine.
Mitotane
The serum concentration of Prednisone can be decreased when it is combined with Mitotane.
Mivacurium
Mivacurium may increase the adverse neuromuscular activities of Prednisone.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Prednisone.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Prednisone.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Prednisone.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Prednisone.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Prednisone.
Nalidixic Acid
The risk or severity of adverse effects can be increased when Prednisone is combined with Nalidixic Acid.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Prednisone.
Nandrolone
Prednisone may increase the fluid retaining activities of Nandrolone.
Nandrolone Decanoate
Prednisone may increase the fluid retaining activities of Nandrolone decanoate.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Prednisone.
Natalizumab
The risk or severity of adverse effects can be increased when Prednisone is combined with Natalizumab.
Nateglinide
The therapeutic efficacy of Nateglinide can be decreased when used in combination with Prednisone.
Nefazodone
The serum concentration of Prednisone can be increased when it is combined with Nefazodone.
Nelfinavir
The serum concentration of Prednisone can be increased when it is combined with Nelfinavir.
Neostigmine
The risk or severity of adverse effects can be increased when Prednisone is combined with Neostigmine.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Prednisone.
Netupitant
The serum concentration of Prednisone can be increased when it is combined with Netupitant.
Nevirapine
The serum concentration of Prednisone can be decreased when it is combined with Nevirapine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Prednisone.
Nicorandil
The risk or severity of adverse effects can be increased when Prednisone is combined with Nicorandil.
Niflumic Acid
The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Prednisone.
Nilotinib
The metabolism of Prednisone can be decreased when combined with Nilotinib.
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Prednisone.
Nintedanib
The serum concentration of Nintedanib can be increased when it is combined with Prednisone.
Norfloxacin
The risk or severity of adverse effects can be increased when Prednisone is combined with Norfloxacin.
O-PHENANTHROLINE
The risk or severity of adverse effects can be increased when Prednisone is combined with 1,10-Phenanthroline.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Prednisone.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Prednisone.
Olaparib
The metabolism of Prednisone can be decreased when combined with Olaparib.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Prednisone.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Prednisone.
Osimertinib
The serum concentration of Prednisone can be increased when it is combined with Osimertinib.
Ouabain
Ouabain may decrease the cardiotoxic activities of Prednisone.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Prednisone.
Oxandrolone
Prednisone may increase the fluid retaining activities of Oxandrolone.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Prednisone.
Oxymetholone
Prednisone may increase the fluid retaining activities of Oxymetholone.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Prednisone.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Prednisone.
Palbociclib
The serum concentration of Prednisone can be increased when it is combined with Palbociclib.
Parecoxib
The risk or severity of adverse effects can be increased when Parecoxib is combined with Prednisone.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Prednisone.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Prednisone.
Pefloxacin
The risk or severity of adverse effects can be increased when Prednisone is combined with Pefloxacin.
Pentobarbital
The serum concentration of Prednisone can be decreased when it is combined with Pentobarbital.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Prednisone.
Phenformin
The therapeutic efficacy of Phenformin can be decreased when used in combination with Prednisone.
Phenobarbital
The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.
Phenylacetic Acid
The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Prednisone.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Prednisone.
Phenylbutyrate
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Prednisone.
Phenytoin
The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.
Physostigmine
The risk or severity of adverse effects can be increased when Prednisone is combined with Physostigmine.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Prednisone.
Pioglitazone
The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Prednisone.
Piretanide
Prednisone may increase the hypokalemic activities of Piretanide.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Prednisone.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Prednisone.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Prednisone.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Prednisone.
Polyestradiol Phosphate
The serum concentration of Prednisone can be increased when it is combined with Polyestradiol phosphate.
Polythiazide
Prednisone may increase the hypokalemic activities of Polythiazide.
Posaconazole
The serum concentration of Prednisone can be increased when it is combined with Posaconazole.
Pramlintide
The therapeutic efficacy of Pramlintide can be decreased when used in combination with Prednisone.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Prednisone.
Primidone
The serum concentration of Prednisone can be decreased when it is combined with Primidone.
Promestriene
The serum concentration of Prednisone can be increased when it is combined with Promestriene.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Prednisone.
Pyridostigmine
The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.
Pyridostigmine Bromide
The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.
Quinestrol
The serum concentration of Prednisone can be increased when it is combined with Quinestrol.
Quinethazone
Prednisone may increase the hypokalemic activities of Quinethazone.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Prednisone is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Prednisone.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Prednisone.
Rapacuronium
Rapacuronium may increase the adverse neuromuscular activities of Prednisone.
Regular Insulin, Human
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Prednisone.
Repaglinide
The therapeutic efficacy of Repaglinide can be decreased when used in combination with Prednisone.
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Prednisone.
Rifabutin
The serum concentration of Prednisone can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Prednisone can be decreased when it is combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Prednisone.
Rilpivirine
The serum concentration of Rilpivirine can be decreased when it is combined with Prednisone.
Ritonavir
The serum concentration of Prednisone can be increased when it is combined with Ritonavir.
Rivastigmine
The risk or severity of adverse effects can be increased when Prednisone is combined with Rivastigmine.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Prednisone.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Prednisone.
Rosiglitazone
The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Prednisone.
Rosoxacin
The risk or severity of adverse effects can be increased when Prednisone is combined with Rosoxacin.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Prednisone.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Prednisone is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Prednisone is combined with Rubella virus vaccine.
Rucaparib
The metabolism of Prednisone can be decreased when combined with Rucaparib.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Prednisone.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Prednisone.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Prednisone is combined with Salmonella typhi ty21a live antigen.
Salsalate
The risk or severity of adverse effects can be increased when Salsalate is combined with Prednisone.
Saquinavir
The serum concentration of Prednisone can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Prednisone can be increased when it is combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Prednisone can be decreased when used in combination with Sarilumab.
Saxagliptin
The serum concentration of Saxagliptin can be decreased when it is combined with Prednisone.
Saxagliptin Anhydrous
The serum concentration of Saxagliptin can be decreased when it is combined with Prednisone.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Prednisone.
Sildenafil
The metabolism of Prednisone can be decreased when combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Prednisone.
Siltuximab
The serum concentration of Prednisone can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Prednisone can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Prednisone.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Prednisone.
Sitagliptin
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Prednisone.
Sitagliptin Phosphate
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Prednisone.
Sodium Bicarbonate
The bioavailability of Prednisone can be decreased when combined with Sodium bicarbonate.
Somatropin
The therapeutic efficacy of Prednisone can be decreased when used in combination with Somatotropin.
Sparfloxacin
The risk or severity of adverse effects can be increased when Prednisone is combined with Sparfloxacin.
ST. JOHN'S WORT EXTRACT
The serum concentration of Prednisone can be decreased when it is combined with St. John's Wort.
Stanozolol
Prednisone may increase the fluid retaining activities of Stanozolol.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Prednisone.
Sulfisoxazole
The metabolism of Prednisone can be decreased when combined with Sulfisoxazole.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Prednisone.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Prednisone.
synthetic conjugated estrogens, A
The serum concentration of Prednisone can be increased when it is combined with Synthetic Conjugated Estrogens, A.
synthetic conjugated estrogens, B
The serum concentration of Prednisone can be increased when it is combined with Synthetic Conjugated Estrogens, B.
Tacrine
The risk or severity of adverse effects can be increased when Prednisone is combined with Tacrine.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Prednisone.
Telaprevir
The serum concentration of Telaprevir can be decreased when it is combined with Prednisone.
Telithromycin
The serum concentration of Prednisone can be increased when it is combined with Telithromycin.
Temafloxacin
The risk or severity of adverse effects can be increased when Prednisone is combined with Temafloxacin.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Prednisone.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Prednisone.
Tesamorelin
The serum concentration of the active metabolites of Prednisone can be reduced when Prednisone is used in combination with Tesamorelin resulting in a loss in efficacy.
Testosterone
Prednisone may increase the fluid retaining activities of Testosterone.
Testosterone Cypionate
Prednisone may increase the fluid retaining activities of Testosterone cypionate.
Testosterone Enanthate
Prednisone may increase the fluid retaining activities of Testosterone enanthate.
Testosterone Propionate
Prednisone may increase the fluid retaining activities of Testosterone propionate.
Testosterone Undecanoate
Prednisone may increase the fluid retaining activities of Testosterone undecanoate.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Prednisone is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Prednisone.
Tibolone
The serum concentration of Prednisone can be increased when it is combined with Tibolone.
Ticlopidine
The metabolism of Prednisone can be decreased when combined with Ticlopidine.
Tocilizumab
The serum concentration of Prednisone can be decreased when it is combined with Tocilizumab.
Tofacitinib
Prednisone may increase the immunosuppressive activities of Tofacitinib.
Tolazamide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Prednisone.
Tolbutamide
The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Prednisone.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Prednisone.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Prednisone.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Prednisone.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Prednisone.
Torsemide
Prednisone may increase the hypokalemic activities of Torasemide.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Prednisone.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Prednisone.
Trichlormethiazide
Prednisone may increase the hypokalemic activities of Trichlormethiazide.
Troglitazone
The therapeutic efficacy of Troglitazone can be decreased when used in combination with Prednisone.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Prednisone.
Tromethamine
The bioavailability of Prednisone can be decreased when combined with Tromethamine.
Trovafloxacin
The risk or severity of adverse effects can be increased when Prednisone is combined with Trovafloxacin.
Tubocurarine
The risk or severity of adverse effects can be increased when Prednisone is combined with Tubocurarine.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Prednisone is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Prednisone is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Prednisone.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Prednisone is combined with Varicella Zoster Vaccine (Live/Attenuated).
Vemurafenib
The serum concentration of Prednisone can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Prednisone can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Prednisone can be decreased when combined with Verapamil.
Vildagliptin
The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Prednisone.
Vincristine
The excretion of Vincristine can be decreased when combined with Prednisone.
Voriconazole
The serum concentration of Prednisone can be increased when it is combined with Voriconazole.
Warfarin
Prednisone may increase the anticoagulant activities of Warfarin.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Prednisone is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Prednisone is combined with Yellow Fever Vaccine.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Prednisone.
Ziprasidone
The metabolism of Prednisone can be decreased when combined with Ziprasidone.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Prednisone.